Iron Triangle Partners LP Catalent, Inc. Transaction History

Iron Triangle Partners LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $18.1 Million - $28.3 Million	250,000 New	250,000 $18.1 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $34.2 Million - $44.8 Million	-392,663 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $7.16 Million - $9.46 Million	76,002 Added 24.0%	392,663 $43.5 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $6.77 Million - $7.88 Million	56,661 Added 21.79%	316,661 $40.5 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $38 Million - $49.6 Million	-348,429 Reduced 57.27%	260,000 $34.6 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $61 Million - $70.4 Million	608,429 New	608,429 $65.8 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $16.2 Million - $20 Million	-160,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $10.3 Million - $12.6 Million	-120,000 Reduced 42.86%	160,000 $16.7 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $3.84 Million - $6.32 Million	80,000 Added 40.0%	280,000 $20.5 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $7.39 Million - $12.6 Million	200,000 New	200,000 $10.4 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

Stay updated on Iron Triangle Partners LP with notifications on news.